86 related articles for article (PubMed ID: 18803955)
1. Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance.
Makita S; Abiko A; Naganuma Y; Moriai Y; Nakamura M
Metabolism; 2008 Oct; 57(10):1473-8. PubMed ID: 18803955
[TBL] [Abstract][Full Text] [Related]
2. Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries.
Gadanec LK; Swiderski J; Apostolopoulos V; Kelaidonis K; Vidali VP; Canko A; Moore GJ; Matsoukas JM; Zulli A
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139391
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of candesartan in inflammatory skin disorders by suppressing Th17 differentiation.
Son SE; Im DS
Int Immunopharmacol; 2023 Nov; 124(Pt B):110995. PubMed ID: 37801970
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome.
Vitale C; Mercuro G; Castiglioni C; Cornoldi A; Tulli A; Fini M; Volterrani M; Rosano GM
Cardiovasc Diabetol; 2005 May; 4():6. PubMed ID: 15892894
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan detection by UV spectrophotometry in mice drinking water.
Gonçalves LF; Fernandes-Santos C
Anal Sci Adv; 2021 Aug; 2(7-8):408-415. PubMed ID: 38715957
[TBL] [Abstract][Full Text] [Related]
6. Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.
Watanabe M; Inukai K; Sumita T; Ikebukuro K; Ito D; Kurihara S; Ono H; Awata T; Katayama S
Intern Med; 2010; 49(17):1843-7. PubMed ID: 20823643
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
Suksomboon N; Poolsup N; Prasit T
J Clin Pharm Ther; 2012 Jun; 37(3):319-27. PubMed ID: 21848583
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus.
Ozaki N; Nomura Y; Sobajima H; Kondo K; Oiso Y
Eur J Intern Med; 2010 Jun; 21(3):236-9. PubMed ID: 20493430
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan versus valsartan in patients with hypertension: effects on cardiovascular, metabolic, and inflammatory parameters.
Lim SY; Kim SW; Kim EJ; Kang JH; Kim SA; Kim YK; Na JO; Choi CU; Lim HE; Han SW; Rha SW; Park CG; Seo HS; Oh DJ
Korean Circ J; 2011 Oct; 41(10):583-9. PubMed ID: 22125557
[TBL] [Abstract][Full Text] [Related]
10. Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients.
Hasegawa H; Takano H; Narumi H; Ohtsuka M; Mizuguchi T; Namiki T; Kobayashi Y; Komuro I
Hypertens Res; 2011 Nov; 34(11):1179-84. PubMed ID: 21796128
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients.
Hong SJ; Choi SC; Ahn CM; Park JH; Kim JS; Lim DS
Heart; 2011 Sep; 97(17):1425-32. PubMed ID: 21700754
[TBL] [Abstract][Full Text] [Related]
12. Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients.
de Luis DA; Conde R; González-Sagrado M; Aller R; Izaola O; Dueñas A; Pérez Castrillón JL; Romero E
Nutr Hosp; 2010; 25(2):275-9. PubMed ID: 20449538
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance.
Perl S; Schmölzer I; Sourij H; Pressl H; Eder M; Zweiker R; Wascher TC
Int J Cardiol; 2010 Mar; 139(3):289-96. PubMed ID: 19118910
[TBL] [Abstract][Full Text] [Related]
14. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
Kishi T; Hirooka Y; Konno S; Sunagawa K
J Hypertens; 2012 Aug; 30(8):1646-55. PubMed ID: 22728908
[TBL] [Abstract][Full Text] [Related]
16. The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO).
Murakami K; Wada J; Ogawa D; Horiguchi CS; Miyoshi T; Sasaki M; Uchida HA; Nakamura Y; Makino H
Diab Vasc Dis Res; 2013 Jan; 10(1):93-6. PubMed ID: 22561230
[TBL] [Abstract][Full Text] [Related]
17. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease.
Zankl AR; Ivandic B; Andrassy M; Volz HC; Krumsdorf U; Blessing E; Katus HA; Tiefenbacher CP
Clin Res Cardiol; 2010 Dec; 99(12):787-94. PubMed ID: 20614124
[TBL] [Abstract][Full Text] [Related]
19. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
[TBL] [Abstract][Full Text] [Related]
20. Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial.
Radonic T; de Witte P; Baars MJ; Zwinderman AH; Mulder BJ; Groenink M;
Trials; 2010 Jan; 11():3. PubMed ID: 20067609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
